A growing number of facilities (42%) are considering changing or adding additional vendors to their outsourcing plan, yet just 9% are currently taking concrete steps to do so.

Most facilities (57%) plan to maintain their current outsourcing volume over the next 3 years, while 26% of pharmacy directors are planning to order additional CSPs from their outsourced vendors.

For those facilities looking to add or switch outsourced compounding vendors, Nephron, CAPS, and Quva are the leading vendors under consideration.